Skip to main content

Table 5 Toxicity and safety

From: Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

 

EG(N = 119),n(%)

CG(N = 98), n(%)

p -value

Radiation dermatitis

 Grade 0

91 (76.5%)

81 (82.7%)

0.264

 GradeI-II

23 (19.3%)

15 (15.3%)

0.438

 Grade III-IV

5 (4.2%)

2 (2.0%)

0.461

Radiation cystitis

 Grade 0

97 (81.5%)

79 (80.6%)

0.866

 GradeI-II

22 (18.5%)

19 (19.4%)

0.866

 Grade III-IV

0 (0%)

0 (0%)

 

Radiation enteritis

 Grade 0

43 (36.1%)

45 (45.9%)

0.144

 GradeI-II

57 (47.9%)

45 (45.9%)

0.771

 Grade III-IV

19 (16%)

8 (8.2%)

0.083

Bone Marrow suppression

 Grade 0

11 (9.25%)

8 (8.2%)

0.779

 GradeI-II

83 (69.75%)

73 (74.5%)

0.439

 Grade III-IV

25 (21.0%)

17 (17.3%)

0.497

  1. EG The experimental group, CG The control group